TransMedics Group (TMDX) PT Lowered to $110 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts TMDX Hot Sheet
Price: $71.76 -0.42%
Rating Summary:
12 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 15
Rating Summary:
12 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 15
Join SI Premium – FREE
Baird analyst David Rescott lowered the price target on TransMedics Group (NASDAQ: TMDX) to $110.00 (from $122.00) while maintaining a Outperform rating.
You May Also Be Interested In
- UCB SA (UCB:BB) (UCBJY) PT Raised to EUR340 at TD Cowen
- Cheesecake Factory (CAKE) PT Raised to $80 at UBS
- Graco Inc. (GGG) PT Lowered to $80 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
